返回
A
Amelia Torcello‐Gómez
Eli Lilly and Company
23H指数
45论文数
1.7K被引数
收录论文 29
发表时间
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to-5 studies每周一次的葡萄糖依赖性促胰岛素多肽和胰高血糖素样肽-1受体激动剂tirzepadide在2型糖尿病中实现减肥和无低血糖的血糖目标: 对SURPASS-1至-5研究的事后分析

